Your browser doesn't support javascript.
loading
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
Schmitt, Andreas M; Herbrand, Amanda K; Fox, Christopher P; Bakunina, Katerina; Bromberg, Jacoline E C; Cwynarski, Kate; Doorduijn, Jeanette K; Ferreri, Andrés J M; Illerhaus, Gerald; Issa, Samar; Schorb, Elisabeth; Zucca, Emanuele; Hemkens, Lars G; Schandelmaier, Stefan; Kasenda, Benjamin.
Afiliación
  • Schmitt AM; Department of Medical Oncology, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Herbrand AK; Department of Medical Oncology, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Fox CP; Department of Clinical Haematology, Nottingham Hospitals NHS Trust, Nottingham, UK.
  • Bakunina K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Bromberg JEC; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Cwynarski K; Department of Haematology, University College London Hospital, London, UK.
  • Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Ferreri AJM; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Illerhaus G; Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
  • Issa S; Department of Hematology, Middlemore Hospital, Auckland, New Zealand.
  • Schorb E; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Zucca E; Istituto Oncologico Della Svizzera Italiana, Bellinzona, Switzerland.
  • Hemkens LG; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland.
  • Schandelmaier S; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland.
  • Kasenda B; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Hematol Oncol ; 37(5): 548-557, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31418878
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Neoplasias del Sistema Nervioso Central / Rituximab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Neoplasias del Sistema Nervioso Central / Rituximab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Suiza